+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transplant Diagnostics Market by Diagnostic Application (Donor Recipient Matching, Graft Monitoring, Hla Typing), Technology (Enzymatic Assays, Flow Cytometry, Pcr), Organ Type, End User - Global Forecast 2025-2030- Product Image
Transplant Diagnostics Market by Diagnostic Application (Donor Recipient Matching, Graft Monitoring, Hla Typing), Technology (Enzymatic Assays, Flow Cytometry, Pcr), Organ Type, End User - Global Forecast 2025-2030- Product Image
Sale

Transplant Diagnostics Market by Diagnostic Application (Donor Recipient Matching, Graft Monitoring, Hla Typing), Technology (Enzymatic Assays, Flow Cytometry, Pcr), Organ Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4986098
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The transplant diagnostics market is experiencing rapid change as advanced testing technologies energize both clinical standards and commercial strategies. With shifting regulatory frameworks and increasing demand for innovative diagnostics, senior leaders must understand how current market forces are shaping investment and operational priorities.

Market Snapshot: Transplant Diagnostics Market Growth Overview

The Transplant Diagnostics Market grew from USD 4.91 billion in 2024 to USD 5.29 billion in 2025. It is expected to continue growing at a CAGR of 7.68%, reaching USD 7.65 billion by 2030. This expansion is fueled by technological progress in genomics, immunoassay platforms, and increasing healthcare emphasis on personalized treatment and early intervention. Global realignment in supply chains and evolving compliance standards continue to influence the competitive landscape.

Scope & Segmentation: Deeper Insights on Transplant Diagnostics

This report offers a comprehensive analysis across every major dimension impacting transplant diagnostics development and adoption:

  • Diagnostic Applications: Donor and recipient matching, graft monitoring, high and low-resolution HLA typing, and infectious disease screening targeting bacterial, fungal, and viral (including cytomegalovirus, Epstein-Barr virus, hepatitis, HIV) agents.
  • Technologies: Enzymatic assays, flow cytometry, PCR (digital PCR and qPCR), and sequencing strategies (next-generation and Sanger).
  • Organ Types: Focus areas include kidney, heart, liver, lung, and pancreas transplantation, reflecting varying diagnostic priorities for each organ.
  • End Users: Diagnostic laboratories prioritizing throughput and quality standards, hospitals (public and private) balancing centralized and point-of-care workflows, research institutes driving biomarker discovery, and transplant centers requiring integrated clinical solutions.
  • Regional Coverage: Analysis spans the Americas (United States including states like California, Texas, and New York, as well as Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (with markets such as the United Kingdom, Germany, France, and emerging hubs like UAE and South Africa), and Asia-Pacific (covering China, India, Japan, Australia, South Korea, and other dynamic economies).
  • Company Developments: Profiles and strategic insights are provided for leaders such as F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., CareDx, Inc., and Natera, Inc.

Key Takeaways: Strategic Insights for Industry Leaders

  • Technological advancements like high-resolution typing and digital PCR accelerate diagnostic speed, precision, and breadth, enhancing routine patient care and risk prediction.
  • Integrated bioinformatics and digital health capabilities are transforming data interpretation and enabling scalable remote monitoring for post-transplant patients.
  • Broader use of multiplexed and modular assay designs supports regional adaptation, operational resilience, and greater clinical reach for manufacturers and labs.
  • Collaboration between technology innovators, academic researchers, and clinical networks is increasing, accelerating biomarker validation and fast-tracking clinical adoption.
  • Emerging economies in Asia-Pacific and Latin America are focusing on infrastructure and workforce enhancement, creating new opportunities and competitive considerations for market participants.
  • Consolidation and strategic alliances among industry front-runners are producing integrated solutions that meet increasing demand for end-to-end diagnostic workflows.

Tariff Impact: How 2025 U.S. Tariffs Are Shaping the Market

Tariffs introduced in the United States in 2025 have increased operational expenditures on imported reagents and specialized instruments. These measures have accelerated the shift toward regional sourcing, larger inventory buffers, and strategic manufacturing partnerships. Diagnostic providers are adapting with modular designs and in-house capabilities to sustain continuity and safeguard innovation pipelines. The reimbursement environment is adjusting too, as both payers and providers reevaluate value creation and budgeting in light of higher costs and shifting supply chains.

Methodology & Data Sources

This analysis integrates secondary research from peer-reviewed journals, regulatory filings, trial registries, and corporate publications with insights gathered from interviews with clinical experts, laboratory directors, and key industry stakeholders. Quantitative data from proprietary surveys and vendor lists, validated through statistical modeling, provide a robust market intelligence framework.

Why This Report Matters to Senior Decision-Makers

  • Supports confident strategic planning, budgeting, and partnership decisions by clarifying critical trends, risks, and opportunities within transplant diagnostics.
  • Delivers detailed competitive benchmarking and regional insights, enabling tailored approaches to market entry, product development, and value-based care alignment.
  • Equips C-suite executives and business unit leaders with actionable intelligence for technology investment, sourcing strategies, and regulatory engagement.

Conclusion

Transplant diagnostics is evolving in response to clinical needs, technological breakthroughs, and global market shifts. Informed, agile strategies—grounded in comprehensive analysis—will be crucial for industry leaders seeking operational and market success amid continued transformation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of liquid biopsy using cell-free DNA assays for early organ rejection detection
5.2. Adoption of AI-driven image analysis for precise histopathological evaluation in transplant diagnostics
5.3. Implementation of multiplex immunoassays for simultaneous monitoring of donor-specific antibodies and immune markers
5.4. Expansion of point-of-care molecular testing platforms to enable rapid detection of transplant-related infections
5.5. Development of noninvasive urinary biomarker panels to predict chronic allograft injury before functional decline
5.6. Regulatory approval and reimbursement challenges influencing market access for gene expression profiling tests in transplantation
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Transplant Diagnostics Market, by Diagnostic Application
8.1. Introduction
8.2. Donor Recipient Matching
8.3. Graft Monitoring
8.4. Hla Typing
8.4.1. High Resolution
8.4.2. Low Resolution
8.5. Infectious Disease Screening
8.5.1. Bacterial Screening
8.5.2. Fungal Screening
8.5.3. Viral Screening
8.5.3.1. Cytomegalovirus
8.5.3.2. Epstein Barr Virus
8.5.3.3. Hepatitis Viruses
8.5.3.4. Hiv
9. Transplant Diagnostics Market, by Technology
9.1. Introduction
9.2. Enzymatic Assays
9.3. Flow Cytometry
9.4. Pcr
9.4.1. Digital Pcr
9.4.2. Qpcr
9.5. Sequencing
9.5.1. Next Generation
9.5.2. Sanger
10. Transplant Diagnostics Market, by Organ Type
10.1. Introduction
10.2. Heart
10.3. Kidney
10.4. Liver
10.5. Lung
10.6. Pancreas
11. Transplant Diagnostics Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Research Institutes
11.5. Transplant Centers
12. Americas Transplant Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Transplant Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Transplant Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche Ltd
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Abbott Laboratories
15.3.4. Danaher Corporation
15.3.5. Illumina, Inc.
15.3.6. Qiagen N.V.
15.3.7. Bio-Rad Laboratories, Inc.
15.3.8. DiaSorin S.p.A.
15.3.9. CareDx, Inc.
15.3.10. Natera, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. TRANSPLANT DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 24. TRANSPLANT DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. TRANSPLANT DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 26. TRANSPLANT DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DONOR RECIPIENT MATCHING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DONOR RECIPIENT MATCHING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GRAFT MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GRAFT MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HIGH RESOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HIGH RESOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LOW RESOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LOW RESOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY BACTERIAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY BACTERIAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FUNGAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FUNGAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CYTOMEGALOVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CYTOMEGALOVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY EPSTEIN BARR VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY EPSTEIN BARR VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEPATITIS VIRUSES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEPATITIS VIRUSES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ENZYMATIC ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ENZYMATIC ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SANGER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SANGER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEART, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEART, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LUNG, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LUNG, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PANCREAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 137. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 140. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 141. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 142. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 143. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 144. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 145. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 148. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 149. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 150. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 151. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 156. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 160. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 161. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 162. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 163. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 164. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 165. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 167. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 168. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 169. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 170. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 171. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 262. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 263. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 264. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 265. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 266. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 267. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 270. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 271. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 272. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 273. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 274. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 275. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 278. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 279. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 282. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 283. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 284. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 285. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 286. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 287. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 288. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 289. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 290. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 291. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 292. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 293. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 294. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 295. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 298. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 319. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2024 (USD MILLION)
TABLE 322. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2025-2030 (USD MILLION)
TABLE 323. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2024 (USD MILLION)
TABLE 324. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2025-2030 (USD MILLION)
TABLE 325. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2024 (USD MILLION)
TABLE 326. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2025-2030 (USD MILLION)
TABLE 327. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 328. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 329. ITAL

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • Illumina, Inc.
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • CareDx, Inc.
  • Natera, Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.65 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Organ Transplant Diagnostics Market by Test Type (Genetic, Histocompatibility, Molecular), Organ Type (Heart, Kidney, Liver), Technology, Application, End User - Global Forecast 2025-2030 - Product Image

Organ Transplant Diagnostics Market by Test Type (Genetic, Histocompatibility, Molecular), Organ Type (Heart, Kidney, Liver), Technology, Application, End User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Transplant Diagnostics Market Report and Forecast 2025-2034 - Product Image

Transplant Diagnostics Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Global Transplant Diagnostics Market Size and Forecast 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product Type, Technology, Transplant Type, and End-user - Product Image

Global Transplant Diagnostics Market Size and Forecast 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product Type, Technology, Transplant Type, and End-user

  • Report
  • 73 Pages
  • Global
From
Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Application, Technology, Transplant Type, End User, and Country - Analysis and Forecast, 2025-2035 - Product Image

Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Application, Technology, Transplant Type, End User, and Country - Analysis and Forecast, 2025-2035

  • Report
  • 140 Pages
  • Global
From
Serological Transplant Diagnostics - Global Strategic Business Report - Product Image

Serological Transplant Diagnostics - Global Strategic Business Report

  • Report
  • 161 Pages
  • Global
From

About the Transplant Diagnostics Market

The Transplant Diagnostics market is a subset of the Diagnostics industry, which focuses on the development and commercialization of tests and technologies used to diagnose and monitor transplant patients. These tests are used to detect and monitor the presence of donor-derived cells, as well as to assess the risk of rejection and other complications. Transplant Diagnostics also includes tests used to detect and monitor infections, such as viruses and bacteria, that can be transmitted through transplanted organs. The Transplant Diagnostics market is driven by the increasing number of organ transplants, as well as the need for improved patient outcomes. Additionally, the development of new technologies and tests, such as next-generation sequencing and mass spectrometry, has enabled more accurate and timely diagnosis and monitoring of transplant patients. Some companies in the Transplant Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Cepheid, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.